JMP Securities maintains Cytokinetics stock with $78 target
JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
Palantir Technologies (PLTR) – The “Messi of AI” Set to Hit $1 Trillion
We recently published a list of 10 Must-Watch AI Stocks Dominating Headlines. In this article, we are going to take a look at ...